Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pharmaceutical Approval Update.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
How long is the presymptomatic phase of multiple sclerosis?
Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis.
[Multiple Sclerosis and Commensal Gut Flora].
[Exogenous evoked potentials in adolesccents with muftiple sclerosis].
Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.
Administrative databases for observational studies in multiple sclerosis: power or peril?
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis.
Imaging Manifestations of Neurologic Complications in Anemia.
Conclusions: Calls to action for improving the life of MS patients and their families.
Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.
Myelinated fibers of the mouse spinal cord after a 30-day space flight.
Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Multislice T1 -prepared 2D single-shot EPI: analysis of a clinical T1 mapping method unbiased by B0 or B1 inhomogeneity.
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
Divided visual attention: A comparison of patients with multiple sclerosis and controls, assessed with an optokinetic nystagmus suppression task.
Phenytoin for neuroprotection - Authors' reply.
Redox-based therapeutics in neurodegenerative disease.
Pages
« first
‹ previous
…
778
779
780
781
782
783
784
785
786
…
next ›
last »